1. Home
  2. GXO vs ALKS Comparison

GXO vs ALKS Comparison

Compare GXO & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GXO
  • ALKS
  • Stock Information
  • Founded
  • GXO 2021
  • ALKS 1987
  • Country
  • GXO United States
  • ALKS Ireland
  • Employees
  • GXO N/A
  • ALKS N/A
  • Industry
  • GXO Transportation Services
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GXO Consumer Discretionary
  • ALKS Health Care
  • Exchange
  • GXO Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • GXO 4.8B
  • ALKS 4.9B
  • IPO Year
  • GXO N/A
  • ALKS 1991
  • Fundamental
  • Price
  • GXO $51.34
  • ALKS $28.26
  • Analyst Decision
  • GXO Buy
  • ALKS Strong Buy
  • Analyst Count
  • GXO 13
  • ALKS 14
  • Target Price
  • GXO $60.62
  • ALKS $41.29
  • AVG Volume (30 Days)
  • GXO 860.9K
  • ALKS 1.9M
  • Earning Date
  • GXO 11-03-2025
  • ALKS 10-23-2025
  • Dividend Yield
  • GXO N/A
  • ALKS N/A
  • EPS Growth
  • GXO N/A
  • ALKS 21.99
  • EPS
  • GXO 0.53
  • ALKS 2.08
  • Revenue
  • GXO $12,683,000,000.00
  • ALKS $1,505,296,000.00
  • Revenue This Year
  • GXO $13.55
  • ALKS N/A
  • Revenue Next Year
  • GXO $6.51
  • ALKS $1.66
  • P/E Ratio
  • GXO $95.09
  • ALKS $13.19
  • Revenue Growth
  • GXO 22.39
  • ALKS N/A
  • 52 Week Low
  • GXO $30.46
  • ALKS $25.17
  • 52 Week High
  • GXO $63.33
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • GXO 48.46
  • ALKS 50.86
  • Support Level
  • GXO $50.08
  • ALKS $26.40
  • Resistance Level
  • GXO $52.09
  • ALKS $28.65
  • Average True Range (ATR)
  • GXO 1.22
  • ALKS 1.14
  • MACD
  • GXO -0.21
  • ALKS -0.12
  • Stochastic Oscillator
  • GXO 35.94
  • ALKS 47.85

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: